DexCom (XTER:DC4) Marketable Securities : €1,882 Mil (As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is DexCom Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. DexCom's Marketable Securities for the quarter that ended in Mar. 2024 was €1,882 Mil.

DexCom's annual Marketable Securities increased from Dec. 2021 (€1,486 Mil) to Dec. 2022 (€1,712 Mil) and increased from Dec. 2022 (€1,712 Mil) to Dec. 2023 (€1,979 Mil).

DexCom Marketable Securities Historical Data

The historical data trend for DexCom's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Marketable Securities Chart

DexCom Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

978.39

1,553.66

1,485.56

1,712.32

1,978.70

DexCom Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															1,815.51	2,253.32	2,433.01	1,978.70	1,882.14

DexCom Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

DexCom (XTER:DC4) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

DexCom Marketable Securities Related Terms

Thank you for viewing the detailed overview of DexCom's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

DexCom (XTER:DC4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (XTER:DC4) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

DXCM:USA DXCM:Mexico D1EX34:Brazil DXCM:Austria

Address

6340 Sequence Drive, San Diego, CA, USA, 92121

Website

https://www.dexcom.com

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

DexCom (XTER:DC4) Headlines

No Headlines